Definitive Healthcare Corp. (DH)
$
3.31
+0.04 (1.21%)
Key metrics
Financial statements
Free cash flow per share
0.4246
Market cap
348.9 Million
Price to sales ratio
1.4072
Debt to equity
0.5595
Current ratio
1.7520
Income quality
-0.0918
Average inventory
0
ROE
-1.0651
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Definitive Healthcare Corp., along with its subsidiaries, offers comprehensive healthcare commercial intelligence across the United States, aimed at supporting varied customer needs from product development through to go-to-market strategies, sales, and marketing execution. The company incurred an interest expense of $14,837,000.00 reflecting its debt servicing obligations, which is an important consideration for its financial health. Additionally, the weighted average number of diluted shares outstanding is 116,640,183.00 illustrating potential dilution effects for shareholders. As it navigates operational costs, the company reported selling, general, and administrative expenses of $133,074,000.00 indicating its overhead expenses during the period. Moreover, the income before tax ratio is -2.51 showcasing the pre-tax margin that reveals operational efficiency, while the net income ratio is -1.64 reflecting the company's overall profitability margin. With innovations in various functional areas, such as sales, marketing, clinical research, and strategic planning, the Definitive Healthcare platform plays a pivotal role in aiding biopharmaceutical and medical device companies, along with healthcare IT firms, thus enriching the healthcare ecosystem significantly. With a market capitalization of $355,301,689.00 the company is classified as a small-cap player, making it an attractive option for niche investors focused on emerging growth opportunities. The stock is affordable at $3.27 suitable for budget-conscious investors eager to explore the healthcare landscape. Furthermore, it is a key player in the Medical - Healthcare Information Services industry, contributing significantly to the overall market landscape while fostering innovation. Despite this, the stock has a low average trading volume of 972,315.00 indicating lower market activity that may appeal to investors seeking less volatility. Lastly, it belongs to the Healthcare sector, driving innovation and growth within the industry and positioning itself harmoniously within the healthcare commercial intelligence space.
Is Definitive Healthcare Corp. (DH) a good investment?
Investing in Definitive Healthcare Corp. (DH) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B-, with a Bearish outlook. Always conduct your own research before investing.
What is Definitive Healthcare Corp. (DH)'s stock forecast?
Analysts predict Definitive Healthcare Corp. stock to fluctuate between $2.15 (low) and $6.27 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Definitive Healthcare Corp.'s market capitalization?
As of 2025-05-30, Definitive Healthcare Corp.'s market cap is $355,301,689, based on 107,341,900 outstanding shares.
How does Definitive Healthcare Corp. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Definitive Healthcare Corp. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Definitive Healthcare Corp. (DH) stock?
To buy Definitive Healthcare Corp. (DH) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for DH. Place an order (Market, Limit, etc.).
What is the best time to invest in Definitive Healthcare Corp.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
How did Definitive Healthcare Corp. perform in the last earnings report?
Revenue: $252,202,000 | EPS: -$3.54 | Growth: 97.77%.
Where can I find Definitive Healthcare Corp.'s investor relations reports?
Visit https://www.definitivehc.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Definitive Healthcare Corp.?
You can explore historical data from here
What is the all-time high and low for Definitive Healthcare Corp. stock?
All-time high: $50.30 (2021-09-17) | All-time low: $2.15 (2025-04-09).
What are the key trends affecting Definitive Healthcare Corp. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
21 days ago
Definitive Healthcare Corp. (NASDAQ:DH ) Q1 2025 - Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Kevin Coop - CEO Rick Booth - CFO Casey Heller - SVP, Finance Conference Call Participants Jared Haase - William Blair Craig Hettenbach - Morgan Stanley David Grossman - Stifel George Hill - Deutsche Bank Jenny Shen - BTIG Operator Welcome to Definitive Healthcare's Q1 2025 Earnings Call. Later, we will conduct a question and answer session.
zacks.com
23 days ago
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.08 per share a year ago.
globenewswire.com
23 days ago
FRAMINGHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2025.
globenewswire.com
a month ago
FRAMINGHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its first quarter ended March 31, 2025, on Thursday, May 8, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.
globenewswire.com
2 months ago
FRAMINGHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted inducement awards. The Committee granted Jeff Moyer, Definitive Healthcare's new SVP of Growth and Sales Operations, an inducement award consisting of 364,432 time-based restricted stock units (“RSUs”), effective April 3, 2025. These awards were individually negotiated and granted as an inducement material to Mr. Moyer's respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
globenewswire.com
3 months ago
FRAMINGHAM, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of two senior leaders, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted inducement awards. The Committee granted Kate Hastings, Definitive Healthcare's new Chief Customer Officer an inducement award consisting of 172,414 time-based restricted stock units (“RSUs”) effective March 3, 2025 and granted Benjamin Graboske, Definitive Healthcare's new EVP, Technology, Engineering and Chief Data Officer an inducement award consisting of 1,018,330 time-based RSUs, effective March 3, 2025. Each of these awards was individually negotiated and was granted as an inducement material to Ms. Hastings' and Mr. Graboske's respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
zacks.com
3 months ago
Teaser: AMRC, DH and AAON have been added to the Zacks Rank #5 (Strong Sell) List on March 4, 2025.
seekingalpha.com
3 months ago
Definitive Healthcare Corp. (NASDAQ:DH ) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Rick Booth - Chief Financial Officer Conference Call Participants Jared Haase - William Blair Hanna Lee - Bank of America Jenny Shen - BTIG David Grossman - Stifel Maxi Ma - Deutsche Bank Johnathan McCary - Raymond James Craig Hettenbach - Morgan Stanley Jeff Garro - Stephens Operator Welcome to Definitive Healthcare's Q4 2024 Earnings Call. [Operator Instructions] I would like to now turn the call over to your host.
zacks.com
3 months ago
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.07 per share a year ago.
globenewswire.com
3 months ago
FRAMINGHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and full year ended December 31, 2024.
See all news
